Page 18 - Nasdaq Cbay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Rating) have been given an average rating of “Buy” by the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one […]

Equities analysts expect CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Rating) to report earnings of ($0.34) per share for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for CymaBay Therapeutics’ earnings, with estimates ranging from ($0.38) to ($0.24). CymaBay Therapeutics posted earnings of ($0.23) per share during the same quarter last year, […]